School of Health and Life SciencesGlasgow Caledonian UniversityGlasgowUK.
Public Health ScotlandGlasgowUK.
Hepatology. 2022 Feb;75(2):369-378. doi: 10.1002/hep.32123. Epub 2021 Dec 6.
It is thought that alcohol intake and body mass index (BMI) interact supra-additively to modulate the risk of cirrhosis, but evidence for this phenomenon is limited. We investigated the interrelationship between alcohol and BMI on the incidence of cirrhosis morbidity for participants of the United Kingdom Biobank (UKB) study.
The primary outcome was the cumulative incidence of cirrhosis morbidity, defined as a first-time hospital admission for cirrhosis (with noncirrhosis mortality incorporated as a competing risk). All UKB participants without a previous hospital admission for cirrhosis were included in the analysis. We determined the ratio of the 10-year cumulative incidence in harmful drinkers versus safe drinkers according to BMI. We also calculated the excess cumulative incidence at 10 years for individuals with obesity and/or harmful alcohol compared to safe drinkers with a healthy BMI of 20-25.0 kg/m . A total of 489,285 UK Biobank participants were included, with mean of 10.7 person-years' follow-up. A total of 2070 participants developed the primary outcome, equating to a crude cumulative incidence of 0.36% at 10 years (95% CI:0.34-0.38). The 10-year cumulative incidence was 8.6 times higher for harmful (1.38%) versus safe drinkers (0.16%) if BMI was healthy. Conversely, it was only 3.6 times higher for obese participants (1.99% vs. 0.56%). Excess cumulative incidence was 1.22% (95% CI:0.89-1.55) for harmful drinkers with a healthy BMI, 0.40% (95% CI:0.34-0.46) for obese individuals drinking at safe levels, and 1.83% (95% CI:1.46-2.20) for obese harmful drinkers (all compared to safe drinkers with a healthy BMI).
Alcohol intake and obesity are independent risk factors for cirrhosis morbidity, but they do not interact supra-additively to modulate the cumulative incidence of this outcome.
据认为,饮酒量和体重指数(BMI)相互作用,呈超相加模式,调节肝硬化的风险,但这种现象的证据有限。我们调查了英国生物银行(UKB)研究参与者中酒精和 BMI 对肝硬化发病率的相互关系。
主要结果是肝硬化发病率的累积发生率,定义为首次因肝硬化住院(包括非肝硬化死亡率作为竞争风险)。所有 UKB 参与者均无肝硬化既往住院史。我们根据 BMI 确定了 10 年内有害饮酒者与安全饮酒者的累积发病率比值。我们还计算了与安全饮酒者(BMI 为 20-25.0kg/m 的健康 BMI)相比,肥胖和/或有害饮酒者 10 年内的超额累积发病率。共纳入 489285 名 UK 生物银行参与者,平均随访 10.7 人年。共有 2070 名参与者出现主要结局,10 年粗累积发生率为 0.36%(95%CI:0.34-0.38)。如果 BMI 健康,有害(1.38%)饮酒者的 10 年累积发生率是安全饮酒者(0.16%)的 8.6 倍。相反,肥胖参与者的比率仅高 3.6 倍(1.99%比 0.56%)。BMI 健康的有害饮酒者的超额累积发生率为 1.22%(95%CI:0.89-1.55),安全饮酒的肥胖者为 0.40%(95%CI:0.34-0.46),肥胖和有害饮酒者为 1.83%(95%CI:1.46-2.20)(均与 BMI 健康的安全饮酒者相比)。
饮酒量和肥胖是肝硬化发病率的独立危险因素,但它们不会相互超相加作用,调节这种结果的累积发生率。